NVO - DaVita shares drop amid update on Ozempic kidney failure study
2023-10-10 18:07:12 ET
More on DaVita
- DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
- DaVita Inc. (DVA) Q2 2023 Earnings Call Transcript
- DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold
- DaVita raised to Buy at UBS on growth trajectory
- Seeking Alpha’s Quant Rating on DaVita
For further details see:
DaVita shares drop amid update on Ozempic kidney failure study